Microbot Medical Inc (MBOT) USD0.01

Sell:$1.50Buy:$1.55$0.10 (6.94%)

Prices delayed by at least 15 minutes
Sell:$1.50
Buy:$1.55
Change:$0.10 (6.94%)
Prices delayed by at least 15 minutes
Sell:$1.50
Buy:$1.55
Change:$0.10 (6.94%)
Prices delayed by at least 15 minutes

Company Information

About this company

Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.

Key people

Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Rachel Vaknin
Chief Financial Officer
Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Juan Diaz-Cartelle
Chief Medical Officer
David J. Wilson
Director
Scott R. Burell
Independent Director
Prattipati Laxminarain
Independent Director
Martin J. Madden
Independent Director
Aileen Ptucha Stockburger
Independent Director
Click to see more

Key facts

  • EPIC
    MBOT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US59503A2042
  • Market cap
    $50.03m
  • Employees
    22
  • Shares in issue
    34.74m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.